Publications
Academic article
- Kathrine Halsøy; Annette Morwena Hope; Calvin Foshaug et al. (2026). Long-term Outcome After Correction of Lower Eyelid Retraction With Donor Sclera in Thyroid Eye Disease. (external link)
- Mikael Thomassen Neset; Roy Miodini Nilsen; Kristian Løvås et al. (2025). Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease. (external link)
- Mikael Thomassen Neset; Arve Ulvik; Kristian Løvås et al. (2025). Insight into the metabolic shifts in Graves’ hyperthyroidism: a study of acylcarnitine and lipid profiles. (external link)
- Hans Olav Ueland; Grethe Åstrøm Ueland; Kristian Løvås et al. (2022). Novel inflammatory biomarkers in thyroid eye disease. (external link)
- Ayyad Ahmad Zartasht Khan; Hans Olav Ueland; Elin Henriette Bohman et al. (2024). Ektropion. (external link)
- Hans Olav Ueland; Kathrine Halsøy; Eyvind Rødahl (2024). Blepharotomy Versus Levator Recession with Adjustable Sutures for Correction of Upper Eyelid Retraction in Thyroid Eye Disease. (external link)
- Olav H. Haugen; Anne Elisabeth Christensen; Maren Larsen Norli et al. (2024). Strabismus surgery in topical anaesthesia with intraoperative suture adjustment in Graves' orbitopathy. (external link)
- Shashi Gulati; Hans Olav Ueland; Olav H. Haugen et al. (2015). Long-term follow-up of patients with thyroid eye disease treated with endoscopic orbital decompression.. (external link)
- Hans Olav Ueland; Mikael Thomassen Neset; Paal Methlie et al. (2023). Molecular Biomarkers in Thyroid Eye Disease: A Literature Review. (external link)
- Hans Olav Ueland; Aleksander Uchermann; Eyvind Rødahl (2014). Levator recession with adjustable sutures for correction of upper eyelid retraction in thyroid eye disease.. (external link)
- Grethe Åstrøm Ueland; Hans Olav Ueland; Ann-Elin Meling Stokland et al. (2023). Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease. (external link)
- Hans Olav Ueland; Roy Miodini Nilsen; Eyvind Rødahl et al. (2019). Hyaluronic acid is superior to autologous fat for treatment of temporal hollowing after lateral orbital wall decompression: A prospective interventional trail. (external link)
- Hans Olav Ueland; Arve Ulvik; Kristian Løvås et al. (2023). Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy. (external link)
- Hans Olav Ueland; Olav H. Haugen; Eyvind Rødahl (2016). Temporal hollowing and other adverse effects after lateral orbital wall decompression. (external link)
- Ann-Elin Meling Stokland; Marie Austdal; Bjørn Gunnar Nedrebø et al. (2023). Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy. (external link)
- Ayyad Ahmad Zartasht Khan; Hans Olav Ueland; Elin Henriette Bohman et al. (2024). Entropion. (external link)
- Hans Olav Ueland; Svein Arthur Hønsi Jensen; Eyvind Rødahl et al. (2026). Outcomes in Norwegian Cohort with Malignant Orbital Tumours. (external link)